SEC Form 4 research
| Issuer | Zentalis Pharmaceuticals, Inc. |
|---|---|
| Tickers | ZNTL |
| Reporting owners | 36 |
| Officers and directors | 20 |
| Last public filing | 2026-10-01 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-01 | 2026-09-30 | Bruns Ingmar | A | 9,727 | $2.18 | Not reported |
| 2026-08-19 | 2026-08-14 | WALTERS GROUP, WALTERS SUSAN BERKLEY, WALTERS WILLIAM THURMAN | P | 4,335,000 | $3.5 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.